Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$6,418,329
+$691,600 QoQ
Shares Held
25,506
-3.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.78%
of 13F equity value
Holder Rank
#1,163
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERIDIAN INVESTMENT COUNSEL INC. holds $23,634,584 across 8 Drug Manufacturers - General names. ABBV ranks #1 (27.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
25,506 | $6,418,329 | |
| 2 | JNJ |
Johnson & Johnson
|
22,704 | $5,766,134 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
31,450 | $3,973,393 | |
| 4 | NVO |
Novo Nordisk A S
|
63,091 | $3,024,582 | |
| 5 | AMGN |
Amgen Inc
|
6,995 | $2,533,029 | |
| 6 | PFE |
Pfizer Inc
|
50,187 | $1,208,502 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,923 | $504,105 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,584 | $206,510 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,418,329 | 25,506 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $5,726,729 | 26,331 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $6,066,637 | 26,551 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $6,159,195 | 26,601 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $4,984,082 | 26,851 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $5,566,736 | 26,569 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $4,779,063 | 26,894 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $5,496,658 | 27,834 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $4,894,151 | 28,534 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $5,227,726 | 28,708 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $4,551,313 | 29,369 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $4,387,879 | 29,437 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $4,105,492 | 30,472 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $4,856,322 | 30,472 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,928,620 | 30,497 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $4,090,720 | 30,480 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,683,632 | 30,580 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,992,501 | 30,797 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $4,236,936 | 31,292 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,504,372 | 32,487 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $3,668,684 | 32,570 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $3,499,726 | 32,339 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $3,430,300 | 32,014 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $2,778,267 | 31,719 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $3,218,733 | 32,784 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,486,079 | 32,630 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||